Related Experiment Video

Updated: Jul 28, 2026

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
09:40

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood

Published on: November 28, 2018

7.7K

Current USDA licensing requirements for recombinant DNA-derived animal biological products

D A Espeseth, P L Joseph, G P Shibley

    Revue Scientifique Et Technique (International Office of Epizootics)
    |May 7, 2020
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    ApprovalBiotechnologyHealth regulationsPublic administrationUnited States of AmericaVaccine

    More Related Videos

    Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test08:58

    Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

    Published on: April 30, 2019

    9.3K
    Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira14:49

    Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

    Published on: August 14, 2021

    5.5K

    Related Concept Videos

    Recombinant DNA01:09

    Recombinant DNA

    Overview
    Transgenic Organisms00:53

    Transgenic Organisms

    Overview
    Recombinant DNA01:09

    Recombinant DNA

    Overview
    The Central Dogma01:20

    The Central Dogma

    The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
    RNA is the Missing Link Between DNA and Proteins
    In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
    Upstream Processing01:27

    Upstream Processing

    Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...